6201 - 6210 of 9148 Results
Title
Year
-
OPENTitle: Elucidating the Role of Site-Specific Nitration of α-Synuclein in the Pathogenesis of Parkinson’s Disease via Protein Semisynthesis and MutagenesisJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 137Issue #: 15Start Page: 5041End Page: 5052Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/ja5131726Best OA location URL: http://infoscience.epfl.ch/record/208178Citation Count: 166
-
OPENTitle: Biomarkers and non-motor symptoms as a function of motor symptom asymmetry in early Parkinson's diseaseJournal Name: NeuropsychologiaPublisher: Elsevier BVVol: 177Issue #:Start Page: 108419End Page: 108419Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2022.108419Best OA location URL: https://doi.org/10.1016/j.neuropsychologia.2022.108419Citation Count: 20
- Investigating Cognitive Global Coordination in normal and autistic children using virtual reality environments – An EEG Study2021RESTRICTEDTitle: Investigating Cognitive Global Coordination in normal and autistic children using virtual reality environments – An EEG StudyJournal Name: 2021 10th International IEEE/EMBS Conference on Neural Engineering (NER)Publisher: IEEEVol:Issue #:Start Page: 1016End Page: 1019Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/ner49283.2021.9441259Citation Count: 4
- Fecal tyrosine decarboxylase and motor response complications in Parkinson's disease2025RESTRICTEDTitle: Fecal tyrosine decarboxylase and motor response complications in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 138Issue #:Start Page: 107947End Page: 107947Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107947Citation Count: 2
-
OPENTitle: Human progenitor cells isolated from the developing cortex undergo decreased neurogenesis and eventual senescence following expansion in vitroJournal Name: Experimental Cell ResearchPublisher: Elsevier BVVol: 312Issue #: 11Start Page: 2107End Page: 2120Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.yexcr.2006.03.012Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0014482706000966Citation Count: 136
-
OPENTitle: Pharmacological validation of TDO as a target for Parkinson’s diseaseJournal Name: The FEBS JournalPublisher: WileyVol: 288Issue #: 14Start Page: 4311End Page: 4331Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/febs.15721Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.15721Citation Count: 29
- Total α-synuclein levels in human blood cells, CSF, and saliva determined by a lipid-ELISA2016RESTRICTEDTitle: Total α-synuclein levels in human blood cells, CSF, and saliva determined by a lipid-ELISAJournal Name: Analytical and Bioanalytical ChemistryPublisher: Springer Science and Business Media LLCVol: 408Issue #: 27Start Page: 7669End Page: 7677Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00216-016-9863-7Citation Count: 29
-
OPENTitle: Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson’s Disease in RodentsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 8Issue #: 2Start Page: 303End Page: 322Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-171248Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd171248?id=journal-of-parkinsons-disease%2Fjpd171248Citation Count: 308
-
OPENTitle: Safety and tolerability of putaminal AADC gene therapy for Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 73Issue #: 20Start Page: 1662End Page: 1669Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3181c29356Best OA location URL: https://n.neurology.org/content/neurology/73/20/1662.full.pdfCitation Count: 430
-
OPENTitle: SNCA-targeted transcriptional repression therapy alleviates pathological and behavioral perturbations in a Parkinson's disease mouse modelJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 23Issue #: 5Start Page: e01049End Page: e01049Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurot.2026.e01049Best OA location URL: https://doi.org/10.1016/j.neurot.2026.e01049Citation Count: 0